前庭神经鞘瘤机器人放射手术生物有效剂量优化的简单计划策略。

IF 3.4 3区 医学 Q2 ENGINEERING, BIOMEDICAL
A Moutsatsos, E Pantelis
{"title":"前庭神经鞘瘤机器人放射手术生物有效剂量优化的简单计划策略。","authors":"A Moutsatsos, E Pantelis","doi":"10.1088/1361-6560/adaf72","DOIUrl":null,"url":null,"abstract":"<p><p>Using the concept of biologically effective dose (BED), the effect of sublethal DNA damage repair (SLR) on the bio-efficacy of prolonged radiotherapy treatments can be quantified (BED<sub>SLR</sub>). Such treatments, lasting more than 20 min, are typically encountered in stereotactic radiosurgery (SRS) applications using the CyberKnife (CK) and Gamma knife systems. Evaluating the plan data from 45 Vestibular Schwannoma (VS) cases treated with single fraction CK-SRS, this work demonstrates a statistically significant correlation between the marginal BED<sub>SLR</sub>delivered to the target (<i>m-</i>BED<sub>SLR</sub>) and the ratio of the mean collimator size weighted by the fraction of total beams delivered with each collimator (wmCs), to the tumor volume (Tv). The correlation between<i>m-</i>BED<sub>SLR</sub>andwmCsTvdatasets was mathematically expressed by the power functionm-BEDSLR=85.21 (±1.7%)⋅(wmCsTv)(0.05±7%) enabling continuous<i>m-</i>BED<sub>SLR</sub>predictions. Using this formula, a specific range of<i>m-</i>BED<sub>SLR</sub>levels can<i>a priori</i>be targeted during treatment planning through proper selection of collimator size(s) for a given tumor volume. Inversely, for a selected set of collimators, the optimization range of<i>m-</i>BED<sub>SLR</sub>can be determined assuming that all beams are delivered with the smallest and largest collimator size. For single collimator cases or when the relative usage of each collimator size is known or estimated, a specific<i>m-</i>BED<sub>SLR</sub>level can be predicted within 3% uncertainty. The proposed equation is valid for the fixed CK collimators and a physical dose prescription (<i>D</i><sub>pr</sub>) of 13 Gy. For alternate<i>D</i><sub>pr</sub>in the range of 11-14 Gy, a linear relationship was found between relative changes of<i>m-</i>BED<sub>SLR</sub>(<i>D</i><sub>pr</sub>) and<i>D</i><sub>pr</sub>with respect to<i>m-</i>BED<sub>SLR</sub>(13 Gy) and 13 Gy, respectively. The proposed methodology is simple and easy to implement in the clinical setting allowing for optimization of the treatment's bio-effectiveness, in terms of the delivered BED, during treatment planning.</p>","PeriodicalId":20185,"journal":{"name":"Physics in medicine and biology","volume":" ","pages":""},"PeriodicalIF":3.4000,"publicationDate":"2025-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A simple plan strategy to optimize the biological effective dose delivered in robotic radiosurgery of vestibular schwannomas.\",\"authors\":\"A Moutsatsos, E Pantelis\",\"doi\":\"10.1088/1361-6560/adaf72\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Using the concept of biologically effective dose (BED), the effect of sublethal DNA damage repair (SLR) on the bio-efficacy of prolonged radiotherapy treatments can be quantified (BED<sub>SLR</sub>). Such treatments, lasting more than 20 min, are typically encountered in stereotactic radiosurgery (SRS) applications using the CyberKnife (CK) and Gamma knife systems. Evaluating the plan data from 45 Vestibular Schwannoma (VS) cases treated with single fraction CK-SRS, this work demonstrates a statistically significant correlation between the marginal BED<sub>SLR</sub>delivered to the target (<i>m-</i>BED<sub>SLR</sub>) and the ratio of the mean collimator size weighted by the fraction of total beams delivered with each collimator (wmCs), to the tumor volume (Tv). The correlation between<i>m-</i>BED<sub>SLR</sub>andwmCsTvdatasets was mathematically expressed by the power functionm-BEDSLR=85.21 (±1.7%)⋅(wmCsTv)(0.05±7%) enabling continuous<i>m-</i>BED<sub>SLR</sub>predictions. Using this formula, a specific range of<i>m-</i>BED<sub>SLR</sub>levels can<i>a priori</i>be targeted during treatment planning through proper selection of collimator size(s) for a given tumor volume. Inversely, for a selected set of collimators, the optimization range of<i>m-</i>BED<sub>SLR</sub>can be determined assuming that all beams are delivered with the smallest and largest collimator size. For single collimator cases or when the relative usage of each collimator size is known or estimated, a specific<i>m-</i>BED<sub>SLR</sub>level can be predicted within 3% uncertainty. The proposed equation is valid for the fixed CK collimators and a physical dose prescription (<i>D</i><sub>pr</sub>) of 13 Gy. For alternate<i>D</i><sub>pr</sub>in the range of 11-14 Gy, a linear relationship was found between relative changes of<i>m-</i>BED<sub>SLR</sub>(<i>D</i><sub>pr</sub>) and<i>D</i><sub>pr</sub>with respect to<i>m-</i>BED<sub>SLR</sub>(13 Gy) and 13 Gy, respectively. The proposed methodology is simple and easy to implement in the clinical setting allowing for optimization of the treatment's bio-effectiveness, in terms of the delivered BED, during treatment planning.</p>\",\"PeriodicalId\":20185,\"journal\":{\"name\":\"Physics in medicine and biology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":3.4000,\"publicationDate\":\"2025-02-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Physics in medicine and biology\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://doi.org/10.1088/1361-6560/adaf72\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ENGINEERING, BIOMEDICAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Physics in medicine and biology","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1088/1361-6560/adaf72","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0

摘要

利用生物有效剂量(BED)的概念,可以量化亚致死DNA损伤修复(SLR)对延长放射治疗生物疗效的影响(BEDSLR)。这种治疗持续时间超过20分钟,通常在使用射波刀(CK)和伽玛刀系统的立体定向放射外科(SRS)应用中遇到。通过对45例接受单一分数CK-SRS治疗的前庭神经鞘瘤(VS)病例的计划数据进行评估,本研究表明,传递到靶点的边际BEDSLR (m-BEDSLR)与平均准直器大小((_w^m)Cs)与肿瘤体积(Tv)的比例之间存在统计学意义上的相关性。m- bedslr与(_w^m)Cs/Tv数据集之间的相关性通过幂函数m- bedslr = 85.21(±1.7%)∙((_w^m)Cs/Tv)^((0.05±7%))进行数学表达,从而实现m- bedslr的连续预测。使用该公式,在制定治疗计划时,通过对给定肿瘤体积适当选择准直器大小,可以先验地确定m- bedslr水平的特定范围。相反,对于选定的一组准直器,假设所有光束都以最小和最大的准直器尺寸发射,则可以确定m- bedslr的优化范围。对于单个准直器的情况,或者当每个准直器尺寸的相对使用量已知或估计时,可以在3%的不确定性内预测特定的m- bedslr水平。该方程适用于固定CK准直器和13 Gy的物理剂量处方(Dpr)。在11 ~ 14 Gy的交替Dpr范围内,m-BEDSLR(Dpr)和Dpr相对于m-BEDSLR(13Gy)和13Gy的相对变化呈线性关系。所提出的方法简单,易于在临床环境中实施,在治疗计划期间,就交付的BED而言,可以优化治疗的生物有效性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
A simple plan strategy to optimize the biological effective dose delivered in robotic radiosurgery of vestibular schwannomas.

Using the concept of biologically effective dose (BED), the effect of sublethal DNA damage repair (SLR) on the bio-efficacy of prolonged radiotherapy treatments can be quantified (BEDSLR). Such treatments, lasting more than 20 min, are typically encountered in stereotactic radiosurgery (SRS) applications using the CyberKnife (CK) and Gamma knife systems. Evaluating the plan data from 45 Vestibular Schwannoma (VS) cases treated with single fraction CK-SRS, this work demonstrates a statistically significant correlation between the marginal BEDSLRdelivered to the target (m-BEDSLR) and the ratio of the mean collimator size weighted by the fraction of total beams delivered with each collimator (wmCs), to the tumor volume (Tv). The correlation betweenm-BEDSLRandwmCsTvdatasets was mathematically expressed by the power functionm-BEDSLR=85.21 (±1.7%)⋅(wmCsTv)(0.05±7%) enabling continuousm-BEDSLRpredictions. Using this formula, a specific range ofm-BEDSLRlevels cana prioribe targeted during treatment planning through proper selection of collimator size(s) for a given tumor volume. Inversely, for a selected set of collimators, the optimization range ofm-BEDSLRcan be determined assuming that all beams are delivered with the smallest and largest collimator size. For single collimator cases or when the relative usage of each collimator size is known or estimated, a specificm-BEDSLRlevel can be predicted within 3% uncertainty. The proposed equation is valid for the fixed CK collimators and a physical dose prescription (Dpr) of 13 Gy. For alternateDprin the range of 11-14 Gy, a linear relationship was found between relative changes ofm-BEDSLR(Dpr) andDprwith respect tom-BEDSLR(13 Gy) and 13 Gy, respectively. The proposed methodology is simple and easy to implement in the clinical setting allowing for optimization of the treatment's bio-effectiveness, in terms of the delivered BED, during treatment planning.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Physics in medicine and biology
Physics in medicine and biology 医学-工程:生物医学
CiteScore
6.50
自引率
14.30%
发文量
409
审稿时长
2 months
期刊介绍: The development and application of theoretical, computational and experimental physics to medicine, physiology and biology. Topics covered are: therapy physics (including ionizing and non-ionizing radiation); biomedical imaging (e.g. x-ray, magnetic resonance, ultrasound, optical and nuclear imaging); image-guided interventions; image reconstruction and analysis (including kinetic modelling); artificial intelligence in biomedical physics and analysis; nanoparticles in imaging and therapy; radiobiology; radiation protection and patient dose monitoring; radiation dosimetry
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信